Clinical Pharmacology: Then & Now

Trends in Phase I studies

Read more

Join Worldwide’s own Sherilyn Adcock, EVP of Medical and Scientific Affairs, as she discusses industry changes in Phase 1 early development programs over recent years.


Chief Scientific Officer, Early Phase Development

Want to learn more about Worldwide Clinical Trials?